EN
HI
Shukra Pharmaceuticals share price chart
Shukra Pharmaceuticals Share Key Metrics
Volume
24.61 L
Market Cap
1813.41 CR
LTQ@LTP
96@41.25
ATP
41.98
Var Margin
50 %
Circuit Range
31.86-47.78
Delivery %
33.19 %
Value
10.33 CR
ASM/GSM
No
Market Lot
1
Summary
SHUKRAPHAR stock price is ₹41.25 as of 13 Aug, 2026. The stock intraday movement has stayed between ₹40.99 and ₹44.00, while Shukra Pharmaceuticals share price 52 week high low is ₹17.06 & ₹65.26.
In terms of trading activity, SHUKRAPHAR share price has recorded a volume of 24,60,859 shares. The Shukra Pharmaceuticals has a market cap of ₹439614440. The stock’s Average Traded Price (ATP) stands at ₹41.98, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 96 @ ₹41.25.
The Shukra Pharmaceuticals upper circuit limit is ₹47.78 & The Shukra Pharmaceuticals lower circuit limit is ₹31.86, with a Value of ₹10.33 CR. The Delivery Percentage for the day is 33.19%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Shukra Pharmaceuticals Fundamentals
P/E Ratio
79.36
P/B Ratio
0
Div. Yield
0.03
Sector P/E
64.16
Sector P/B
3.28
Sec. Div. Yield
0.51
Shukra Pharmaceuticals Resistance and Support
Pivot 38.03
Resistance
First Resistance
42.06
Second Resistance
44.29
Third Resistance
48.32
Support
First Support
35.8
Second Support
31.77
Third Support
29.54
Shukra Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Aug 13 2026 | 42.99 | 41.25 | 3.62% | 44 | 40.99 |
| Wed Aug 12 2026 | 37 | 39.81 | 6.87% | 40.25 | 34 |
| Tue Aug 11 2026 | 41.04 | 37.25 | -7.06% | 41.04 | 35.79 |
Shukra Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-06-10 | Others |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-03-16 | Others |
| 2026-02-04 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-10-03 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-06-04 | Final Dividend |
| 2025-05-29 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2025-01-29 | Stock Split |
| 2025-01-09 | Others |
| 2024-11-14 | Quarterly Results |
| 2024-09-28 | Rights issue of Equity Shares |
| 2024-08-12 | Quarterly Results |
Shukra Pharmaceuticals News
Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Quartely Results June 30, 2026
Shukra Pharmaceuticals reported robust Q1 FY27 results. Standalone net profit reached ₹15.03 crores, a 1360% increase YoY, while consolidated net profit hit ₹12.96 crores. Revenue from operations for the quarter stood at ₹23.52 crores.
Aug 12 2026 14:39:35
Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Intimation for Quarterly Results
Shukra Pharmaceuticals' board of directors is scheduled to meet on August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The meeting will also review the Auditor's Limited Review Report for the quarter.
Jul 30 2026 19:19:03
Shukra Pharmaceuticals Management
| Name | Position |
|---|---|
| Dakshesh Rameshchandra Shah | Managing Director |
| Payal Mehta | Executive Director |
Shukra Pharmaceuticals Similar Stocks
Venus Remedies Ltd.
1739.85
82.85 (5.00%)
Indoco Remedies Ltd.
221.95
5.25 (2.42%)
Windlas Biotech Ltd.
947.85
52.70 (5.89%)
Krsnaa Diagnostics Ltd.
563.65
-10.70 (1.86%)
Shalby Ltd.
156.00
-1.00 (0.64%)
Amrutanjan Health Care Ltd.
491.85
4.65 (0.95%)
Jagsonpal Pharmaceuticals Ltd.
231.20
5.25 (2.32%)
Fermenta Biotech Ltd.
461.55
-11.85 (2.50%)
Syncom Formulations (India) Ltd.
15.26
-0.62 (3.90%)
Shukra Pharmaceuticals FAQs
The Buying Price of Shukra Pharmaceuticals share is 41.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Shukra Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Shukra Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Shukra Pharmaceuticals shares is 79.36. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Shukra Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Shukra Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.16 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Shukra Pharmaceuticals is 1813.41 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Shukra Pharmaceuticals share price is 65.26 & 17.06. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Shukra Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SHUKRAPHAR
Or Download Choice FinX App
Invest in SHUKRAPHAR
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade